Kellerhals Carrard, Friedrich Graf von Westphalen & Partner, WST – Studio Associato Servizi Professionali Integrati, bpv BRAUN PARTNERS, Hall & Wilcox, Hall Booth Smith, and Ypsilon...
eps Event Group and NÜSSLI Combine to Form Global Leader in Event Infrastructure
Vam Investments Secures Acquisition Financing for Groupe Chaumont Expansion
Kellerhals Carrard, McDermott Will & Schulte, and Spada Partners have advised Vam Investments. Kellerhals Carrard has advised Vam Investments on acquisition financing. VISCHER has advised the...
Spitäler Schaffhausen Secures CHF 160 Million Financing for Hospital Development
Kellerhals Carrard has advised Spitäler Schaffhausen as borrower. Advestra has acted for Zürcher Kantonalbank. Spitäler Schaffhausen has secured a total of CHF 160 million in financing...
Sale of Majority Stake in Hipp Technology Group to Deutsche Beteiligungs AG
Kellerhals Carrard has advised the shareholders of Hipp Technology Group AG and Endura AG. An investor group represented by Endura AG has sold a majority stake...
P&F Immobilien AG Sells Real Estate Portfolio Company to SFP Retail AG
Kellerhals Carrard has advised P&F Immobilien AG. P&F Immobilien AG has completed the sale of all shares in its subsidiary, P&F Immobilien II AG, to SFP...
PostFinance Completes Sale of 3.5% Stake in Swissquote
Kellerhals Carrard has advised PostFinance. PostFinance Ltd has concluded the placement of 536,000 shares in Swissquote Group Holding Ltd through an accelerated bookbuilding process, representing approximately...
Check Point Software Acquires AI Security Startup Lakera
Kellerhals Carrard has advised Lakera and its early investors Atomico and Redalpine. Check Point Software Technologies Ltd., a NASDAQ-listed leader in cybersecurity solutions, has entered into...
DRS Investment Acquires Majority Stake in Newly Formed Factory Group
Kellerhals Carrard has advised DRS Investment SE. Gütt Olk Feldhaus has advised factory Group. McDermott Will & Emery has advised ELF Capital on the financing of...
HAYA Therapeutics SA’s $65 Million Series A Funding Round
Lenz & Staehelin acted for Eli Lilly; Kellerhals Carrard advised Sofinnova Partners and Earlybird Venture Capital; VISCHER acted for HAYA Therapeutics AG. Wilson Sonsini Goodrich &...
MoonLake Immunotherapeutics’ $500 Million Debt Financing with Hercules Capital
Kellerhals Carrard acted as Swiss counsel to MoonLake Immunotherapeutics on this transaction. DLA Piper and Schellenberg Wittmer acted as legal counsel to Hercules Capital. MoonLake Immunotherapeutics...
Adragos Pharma’s Acquisition of Baccinex
Pestalozzi advised Adragos Pharma on the deal, while Kellerhals Carrard advised the seller. Adragos Pharma, a global pharmaceutical contract development and manufacturing organization (CDMO) headquartered in...
Rhenopharma Group’s Acquisition Of Kenopharma AG
Kellerhals Carrard advised Rhenopharma Group in this acquisition. Rhenopharma Group, a leading service provider in the pharmaceutical sector headquartered in Basel, acquired Konapharma AG, a contract...